Literature DB >> 2552112

The glucagonoma syndrome.

M L Price1, C R Darley, N Kirkham.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2552112      PMCID： PMC1292305          DOI： 10.1177/014107688908200917

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  4 in total

1.  A dermatosis specifically associated with a tumour of pancreatic alpha cells.

Authors:  R D Sweet
Journal:  Br J Dermatol       Date:  1974-03       Impact factor: 9.302

2.  Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue.

Authors:  R G Long; A J Barnes; T E Adrian; C N Mallinson; M R Brown; W Vale; J E Rivier; N D Christofides; S R Bloom
Journal:  Lancet       Date:  1979-10-13       Impact factor: 79.321

3.  Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.

Authors:  P R Vandersteen; B W Scheithauer
Journal:  J Am Acad Dermatol       Date:  1985-06       Impact factor: 11.527

4.  Elevated plasma proglucagon-like component with a glucagon-secreting tumor. Effect of streptozotocin.

Authors:  D N Danforth; T Triche; J L Doppman; R M Beazley; P V Perrino; L Recant
Journal:  N Engl J Med       Date:  1976-07-29       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.